Lortet S, Zimmer H G
Department of Physiology, University of Munich, Federal Republic of Germany.
Cardiovasc Res. 1989 Aug;23(8):702-8. doi: 10.1093/cvr/23.8.702.
Ribose improves the function of the rat heart in various pathological conditions through its effects on cardiac energy metabolism, while having no direct haemodynamic actions. We therefore studied its functional and metabolic effects in closed chest rats when given in combination with prazosin, verapamil or metoprolol, all of which have direct effects on the circulation. Ribose administration for 24 h at 200 mg.kg-1.h-1 did not affect heart function but increased the available pool of 5-phosphoribosyl-1-pyrophosphate in heart (four fold) and skeletal muscle (1.7-fold), as assessed by the incorporation of 14C-adenine into the adenine nucleotides. The utilisation of adenine for adenine nucleotide synthesis, expressed as the ratio of adenine nucleotide radioactivity to tissue extract radioactivity, was 70% in heart and 20% in skeletal muscle under control conditions, and 97% and 88% after 24 h of ribose administration. Ribose decreased the 14C-adenine incorporation into the adenine nucleotides in kidney, lungs and liver. After 24 h infusion of prazosin (100 micrograms.kg-1.h-1), heart rate and LVdP/dtmax were not changed, but LVSP (-20%), mean aortic pressure (-16%) and peripheral resistance (-40%) were decreased. Cardiac output was enhanced (+40%). Verapamil (2mg.kg-1.h-1) and metoprolol (2mg.kg-1.h-1) infused for 24 h decreased the pressure-rate and pressure-volume product of the left ventricle to the same extent (-40%). Verapamil had no influence on cardiac output, while metoprolol depressed it (-30%). Simultaneous administration of prazosin, verapamil or metoprolol with ribose did not affect the ribose induced increase in the myocardial 5-phosphoribosyl-1-pyrophosphate pool.(ABSTRACT TRUNCATED AT 250 WORDS)
核糖通过对心脏能量代谢的影响,改善了处于各种病理状态下大鼠心脏的功能,而无直接血流动力学作用。因此,我们研究了在与哌唑嗪、维拉帕米或美托洛尔联合给药时,其对闭胸大鼠的功能和代谢影响,这三种药物均对循环有直接作用。以200mg·kg⁻¹·h⁻¹的剂量给予核糖24小时,对心脏功能无影响,但心脏(增加四倍)和骨骼肌(增加1.7倍)中5-磷酸核糖-1-焦磷酸的有效池增加,这是通过将¹⁴C-腺嘌呤掺入腺嘌呤核苷酸来评估的。在对照条件下,用于腺嘌呤核苷酸合成的腺嘌呤利用率,以腺嘌呤核苷酸放射性与组织提取物放射性之比表示,心脏中为70%,骨骼肌中为20%,给予核糖24小时后分别为97%和88%。核糖减少了¹⁴C-腺嘌呤在肾脏、肺和肝脏中掺入腺嘌呤核苷酸。输注哌唑嗪(100μg·kg⁻¹·h⁻¹)24小时后,心率和左心室dp/dtmax无变化,但左心室收缩压(-20%)、平均主动脉压(-16%)和外周阻力(-40%)降低。心输出量增加(+40%)。输注维拉帕米(2mg·kg⁻¹·h⁻¹)和美托洛尔(2mg·kg⁻¹·h⁻¹)24小时,左心室压力-速率和压力-容积乘积降低程度相同(-40%)。维拉帕米对心输出量无影响,而美托洛尔使其降低(-30%)。哌唑嗪、维拉帕米或美托洛尔与核糖同时给药,不影响核糖诱导的心肌5-磷酸核糖-1-焦磷酸池增加。(摘要截短至250字)